VR Logo

Cadila Healthcare Ltd.


Healthcare | Drugs & Pharma

we think vacations are for wimps

42 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Incorporated: 1995

Chairman: Pankaj R Patel

Managing Director: Sharvil P Patel

Group: Cadila

Listing: NSE: CADILAHC, BSE: 532321

Headquarters: Ahmedabad, Gujarat

Website: www.zyduscadila.com

Key Facts

Market cap: R 53,951.24 Cr

Revenue (TTM): R 15,007.60 Cr

Earnings (TTM): R 1,819.50 Cr

Cash: R 1,177.70 Cr

Total Debt: R 7,999.30 Cr

Promoters' ownership: 74.88%

Liquidity: High

52 Week range: R 318.00 - 532.05

Face value: R1.00

Shares outstanding: 1,02,37,42,600

10 Years Aggregate:

  • CFO: 11,605.30 Cr
  • EBITDA: 18,986.90 Cr
  • Net Profit: 12,308.80 Cr

Stock Performance

Time Period Cadila Healthcare S&P BSE Sensex S&P BSE Healthcare
YTD10.562.266.11
1 month19.81-3.048.99
3 months8.06-0.414.41
1 Year53.4359.5753.44
3 Years10.4812.4818.47
5 Years10.4613.738.21
10 Years12.079.6714.10
As on 16-Apr-2021
Year Cadila Healthcare S&P BSE Sensex S&P BSE Healthcare
202087.5115.7561.45
2019-27.3514.38-3.55
2018-19.525.87-5.89
201721.5527.910.49
20167.201.95-12.88
20151.60-5.0315.06
2014100.2829.8947.43